List view / Grid view

Victoria Rees (Drug Target Review)

 

article

The growth of cell line development

7 April 2022 | By

The rising number of biologics approved for therapeutic use has placed an emphasis on safe and efficient production lines. Here, Drug Target Review’s Editor Victoria Rees considers why biotherapeutic development is likely to prompt significant growth for the cell line market in the next decade.